Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | RAF1 | P04049 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6477861 | 0.88 | KMT2A (0.50) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL31440788 | 0.88 | KMT2A (0.61) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL903579 | 0.86 | MAPK14 (0.62) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL13170085 | 0.86 | CYP1A2 (0.72) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL20357363 | 0.86 | MAPT (0.58) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL1634759 | 0.85 | MAPT (0.56) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL6114199 | 0.85 | MAPT (0.51) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL8370046 | 0.85 | MAPT (0.57) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL5789931 | 0.84 | MAPT (0.74) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 | |
| SCHEMBL17891688 | 0.82 | RXFP1 (0.50) | MAPTKDM4ECYP1A2CYP2C19CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111988996-A | Increasing yield of nut bearing plants | UPL有限责任公司 | 2020-11-24 | — | — | CN | claimed |
| US-20190254281-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | UPL CORPORATION LTD. (MU) | 2019-08-22 | — | — | US | claimed |
| WO-2019161274-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | UPL CORPORATION LTD. (MU) | 2019-08-22 | — | — | WO | claimed |
| EP-2611806-A1 | DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | Ascepion Pharmaceuticals, Inc. (CN) | 2013-07-10 | — | — | EP | claimed |
| EP-2298311-B1 | w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors | BAYER HEALTHCARE LLC (US) | 2012-05-09 | — | — | EP | claimed |
| WO-2012028106-A1 | DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | ASCEPION PHARMACEUTICALS, INC. (CN) | 2012-03-08 | — | — | WO | claimed |
| EP-1158985-B1 | OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS | BAYER HEALTHCARE LLC (US) | 2011-12-28 | — | — | EP | claimed |
| US-6872726-B2 | Fluorinated di-aryl urea compounds | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2005-03-29 | — | — | US | claimed |
| WO-2001064036-A1 | ENHANCEMENT OF SEED/FRUIT/NUT YIELDS FROM FLOWERING PLANTS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2001-09-07 | — | — | WO | claimed |
| US-6242385-B1 | SEEDS OF LEGUME PLANTS, APPLYING TO FOLAGE DURING REPRODUCTION PHENYLUREA DERIVATIVES | UNIROYAL CHEMICAL COMPANY, INC. | 2001-06-05 | — | — | US | claimed |
| EP-4328218-A2 | PHARMACEUTICAL PREPARATION COMPRISING AN ANTIVIRAL DIHYDROQUINAZOLINE DERIVATIVE | AIC246 AG & Co. KG (DE) | 2024-02-28 | — | — | EP | disclosed |
| CN-111988996-B | Improving yield of nut bearing plants | UPL有限责任公司 | 2023-07-14 | — | — | CN | disclosed |
| US-11641859-B2 | Enhanced yield in nut bearing plants | UPL CORPORATION LTD. (MU) | 2023-05-09 | — | — | US | disclosed |
| CN-111988996-A | Increasing yield of nut bearing plants | UPL有限责任公司 | 2020-11-24 | — | — | CN | disclosed |
| WO-2019161274-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | UPL CORPORATION LTD. (MU) | 2019-08-22 | — | — | WO | disclosed |
| EP-2611806-A1 | DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | Ascepion Pharmaceuticals, Inc. (CN) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012028106-A1 | DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | ASCEPION PHARMACEUTICALS, INC. (CN) | 2012-03-08 | — | — | WO | disclosed |
| CN-1341098-A | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | BAYER AG (US) | 2002-03-20 | — | — | CN | disclosed |
| WO-2001064036-A1 | ENHANCEMENT OF SEED/FRUIT/NUT YIELDS FROM FLOWERING PLANTS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2001-09-07 | — | — | WO | disclosed |
| US-6242385-B1 | SEEDS OF LEGUME PLANTS, APPLYING TO FOLAGE DURING REPRODUCTION PHENYLUREA DERIVATIVES | UNIROYAL CHEMICAL COMPANY, INC. | 2001-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190254281-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | NUTF2, MYCBP, MYCBP2 | MAPT 1882/4885KDM4E 3464/4885CYP1A2 1090/4885 |
| US-11641859-B2 | Enhanced yield in nut bearing plants | NUTF2, MYCBP, MYCBP2 | MAPT 1882/4885KDM4E 3464/4885CYP1A2 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.